NT5E and ovarian carcinoma: Previous research has demonstrated the effect of antibodies against CD39 and CD73 in the immune response against ovarian cancer cell lines; it was found that NK and T cell cytotoxicity was improved and the proliferation of CD4+ T cells were uninhibited.